Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunschwig, E. B.
Right arrow Articles by Markowitz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunschwig, E. B.
Right arrow Articles by Markowitz, S.
[Cancer Research 63, 1568-1575, April 1, 2003]
© 2003 American Association for Cancer Research


Molecular Biology and Genetics

PMEPA1, a Transforming Growth Factor-ß-induced Marker of Terminal Colonocyte Differentiation Whose Expression Is Maintained in Primary and Metastatic Colon Cancer1

Elaine B. Brunschwig, Keith Wilson, David Mack, Dawn Dawson, Earl Lawrence, James K.V. Willson, ShiLong Lu, Arman Nosrati, Ronald M. Rerko, Sandra Swinler, Lydia Beard, James D. Lutterbaugh, Joseph Willis, Petra Platzer and Sanford Markowitz2

Howard Hughes Medical Institute [E. B. B., R. M. R., J. D. L., P. P., S. M.], Department of Medicine [E. B. B., E. L, J. K. V. W., S. L., A. N., S. S., L. B., S. M.], Ireland Cancer Center [D. D., J. K. V. W., J. W., S. M.], and Department of Pathology [D. D., J. W.], Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 44106, and Eos Biotechnology, South San Francisco, California 94080 [K. W., D. M.]

To identify potential effectors of transforming growth factor (TGF)-ß-mediated suppression of colon cancer, we used GeneChip® expression microarrays to identify TGF-ß-induced genes in VACO 330, a nontransformed TGF-ß-sensitive cell line derived from a human adenomatous colon polyp. PMEPA1 was identified as a gene highly up-regulated by TGF-ß treatment of VACO 330. Northern blot analysis confirmed TGF-ß induction of PMEPA1 in VACO 330, as well as a panel of three other TGF-ß-sensitive colon cell lines. PMEPA1 induction could be detected as early as 2 h after TGF-ß treatment and was not inhibited by pretreatment of cells with cycloheximide, suggesting that PMEPA1 is a direct target of TGF-ß signaling. Wild-type PMEPA1 and an alternative splice variant lacking the putative transmembrane domain were encoded by the PMEPA1 locus and were shown by epitope tagging to encode proteins with differing subcellular localization. Both variants were found to be expressed in normal colonic epithelium, and both were shown to be induced by TGF-ß. Consistent with TGF-ß playing a role in terminal differentiation of colonocytes, in situ hybridization of normal colonic epithelium localized PMEPA1 expression to nonproliferating, terminally differentiated epithelium located at the top of colonic crypts. Intriguingly, in situ hybridization and Northern blot analysis showed that the expression of PMEPA1 was well maintained both in colon cancer primary tumors and in colon cancer liver metastases. PMEPA1 is thus a novel TGF-ß-induced marker of a differentiated crypt cell population. Moreover, as PMEPA1 expression is maintained, presumptively in a TGF-ß-independent manner after malignant transformation and metastasis, it demonstrates that even late colon cancers retain a strong capacity to execute many steps of the normal colonic differentiation program.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Li, L. L. Xu, K. Masuda, E. Raymundo, D. G. McLeod, A. Dobi, and S. Srivastava
A Feedback Loop between the Androgen Receptor and a NEDD4-binding Protein, PMEPA1, in Prostate Cancer Cells
J. Biol. Chem., October 24, 2008; 283(43): 28988 - 28995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Guo, X. Zhang, S. P. Fink, P. Platzer, K. Wilson, J. K.V. Willson, Z. Wang, and S. D. Markowitz
Ugene, a Newly Identified Protein That Is Commonly Overexpressed in Cancer and Binds Uracil DNA Glycosylase
Cancer Res., August 1, 2008; 68(15): 6118 - 6126.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Reichling, K. H. Goss, D. J. Carson, R. W. Holdcraft, C. Ley-Ebert, D. Witte, B. J. Aronow, and J. Groden
Transcriptional Profiles of Intestinal Tumors in ApcMin Mice are Unique from those of Embryonic Intestine and Identify Novel Gene Targets Dysregulated in Human Colorectal Tumors
Cancer Res., January 1, 2005; 65(1): 166 - 176.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. L. Xu, Y. Shi, G. Petrovics, C. Sun, M. Makarem, W. Zhang, I. A. Sesterhenn, D. G. McLeod, L. Sun, J. W. Moul, et al.
PMEPA1, an Androgen-regulated NEDD4-binding Protein, Exhibits Cell Growth Inhibitory Function and Decreased Expression during Prostate Cancer Progression
Cancer Res., August 1, 2003; 63(15): 4299 - 4304.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.